The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Dehydroepiandrosterone Activates Mutant Androgen Receptors Expressed in the Androgen-Dependent Human Prostate Cancer Xenograft CWR22 and LNCaP Cells
Abstract
An androgen receptor (AR) gene mutation identified in the androgen-dependent human prostate cancer xenograft, CWR22, changed codon 874 in the ligand-binding domain (exon H) from CAT for histidine to TAT for tyrosine and abolished a restriction site for the endonuclease SfaNI. SfaNI digestion of AR exon H DNA from normal but not from prostate cancer tissue indicated H874Y is a somatic mutation that occurred before the initial tumor transplant. CWR22, an epithelial cell tumor, expresses a 9.6-kb AR mRNA similar in size to the AR mRNA in human benign prostatic hyperplasia. AR protein is present in cell nuclei by immunostaining as in other androgen-responsive tissues. Transcriptional activity of recombinant H874Y transiently expressed in CV1 cells in the presence of testosterone or dihydrotestosterone was similar to that of wild type AR. With dihydrotestosterone at a near physiological concentration (0.01 nM), H874Y and wild type AR induced 2-fold greater luciferase activity than did the LNCaP mutant AR T877A. The adrenal androgen, dehydroepiandrosterone (10 and 100 nM) with H874Y stimulated a 3- to 8-fold greater response than with wild type AR and at 100 nM the response was similar with the LNCaP mutant. H874Y, like the LNCaP cell mutant, was more responsive to estradiol and progesterone than was wild type AR. The antiandrogen hydroxyflutamide (10 nM) had greater agonist activity (4- to 7-fold) with both mutant ARs than with wild type AR. AR mutations that alter ligand specificity may influence tumor progression subsequent to androgen withdrawal by making the AR more responsive to adrenal androgens or antiandrogens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,725
Cloning of a novel receptor expressed in rat prostate and ovary.
Kuiper, G. G., Enmark, E., Pelto-Huikko, M., Nilsson, S., & Gustafsson, J. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5925 · Cited by 4,788
LNCaP model of human prostatic carcinoma.
Horoszewicz, J. S., Leong, S. S., Kawinski, E., Karr, J. P., Rosenthal, H. E., Chu, T. M., MIRAND, E. A., & Murphy, G. P. (1983) · PubMed · Cited by 1,789
Androgen Receptor Defects: Historical, Clinical, and Molecular Perspectives*
QUIGLEY, C. A., BELLIS, A. D., MARSCHKE, K. B., EL-AWADY, M. K., WILSON, E. M., & FRENCH, F. S. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-3-271 · Cited by 1,447
Mutation of the Androgen-Receptor Gene in Metastatic Androgen-Independent Prostate Cancer
Taplin, M.-E., Bubley, G. J., Shuster, T. D., Frantz, M. E., Spooner, A. E., Ogata, G. K., Keer, H. N., & Balk, S. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505253322101 · Cited by 1,253
DUNN, J. F., NISULA, B. C., & RODBARD, D. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-53-1-58 · Cited by 1,238 · cited 4×
“whereas free estradiol is 1–2% of the total (20).”
BackgroundInfluentialCloning of Human Androgen Receptor Complementary DNA and Localization to the X Chromosome
Lubahn, D. B., Joseph, D. R., Sullivan, P. M., Willard, H. F., French, F. S., & Wilson, E. M. (1988) · Science · doi:10.1126/science.3353727 · Cited by 1,016
A canonical structure for the ligand-binding domain of nuclear receptors
Wurtz, J.-M., Bourguet, W., Renaud, J.-P., Vivat, V., Chambon, P., Moras, D., & Gronemeyer, H. (1996) · Nature Structural Biology · doi:10.1038/nsb0196-87 · Cited by 985
Veldscholte, J., Ris-Stalpers, C., Kuiper, G. G. J. M., Jenster, G., Berrevoets, C., Claassen, E., van Rooij, H. C. J., Trapman, J., Brinkmann, A. O., & Mulder, E. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)80067-1 · Cited by 950
Čulig, Z., Hobisch, A., Cronauer, M. V., Radmayr, C., Trapman, J., Hittmair, A., Bartsch, G., & Klocker, H. (1994) · PubMed · Cited by 938
A structural role for hormone in the thyroid hormone receptor
Wagner, R. L., Apriletti, J. W., McGrath, M. E., West, B. L., Baxter, J. D., & Fletterick, R. J. (1995) · Nature · doi:10.1038/378690a0 · Cited by 929
Transcriptional activation and nuclear targeting signals of the human androgen receptor.
Simental, J. A., Sar, M., Lane, M. V., French, F. S., & Wilson, E. M. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52466-2 · Cited by 631
Self-citationLubahn, D. B., Joseph, D. R., Sar, M., Tan, J.-A., Higgs, H. N., Larson, R. E., French, F. S., & Wilson, E. M. (1988) · Molecular Endocrinology · doi:10.1210/mend-2-12-1265 · Cited by 570
Self-citationLubahn, D. B., Brown, T. R., Simental, J. A., Higgs, H. N., Migeon, C. J., Wilson, E. M., & French, F. S. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.23.9534 · Cited by 452
Culig, Z. (1993) · Molecular Endocrinology · doi:10.1210/me.7.12.1541 · Cited by 440
Activation of the human androgen receptor through a protein kinase A signaling pathway.
Nazareth, L. V., & Weigel, N. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.33.19900 · Cited by 429
Androgen receptor gene mutations in human prostate cancer.
Newmark, J. R., Hardy, D. O., Tonb, D. C., Carter, B. S., Epstein, J. I., Isaacs, W. B., Brown, T. R., & Barrack, E. R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.14.6319 · Cited by 419
Flutamide withdrawal syndrome: its impact on clinical trials in hormone-refractory prostate cancer.
Scher, H. I., & Kelly, W. K. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.8.1566 · Cited by 405
Tilley, W. D., Buchanan, G., Hickey, T. E., & Bentel, J. M. (1996) · PubMed · Cited by 396
Androgen receptors in endocrine‐therapy‐resistant human prostate cancer
van der Kwast, T. H., Schalken, J., de Winter, J. A. R., van Vroonhoven, J. C. C., Mulder, E., Boersma, W., & Trapman, J. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910480206 · Cited by 386
Wong, C.-I., Kelce, W. R., Sar, M., & Wilson, E. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.34.19998 · Cited by 337
Autologous Down-Regulation of Androgen Receptor Messenger Ribonucleic Acid
Quarmby, V. E., Yarbrough, W. G., Lubahn, D. B., French, F. S., & Wilson, E. M. (1990) · Molecular Endocrinology · doi:10.1210/mend-4-1-22 · Cited by 268
Israeli, R., Miller, W. H., Su, S. L., et al. (1994) · PubMed · Cited by 233
CWR22: androgen-dependent xenograft model derived from a primary human prostatic carcinoma.
Wainstein, M. A., He, F., Robinson, D. R., Kung, H., Schwartz, S., Giaconia, J. M., Edgehouse, N. L., Pretlow, T. P., Bodner, D. R., & Kursh, E. D. (1994) · PubMed · Cited by 225
A tyrosine kinase profile of prostate carcinoma.
Robinson, D., He, F., Pretlow, T., & Kung, H. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5958 · Cited by 207
Aberrant response in vitro of hormone‐responsive prostate cancer cells to antiandrogens
Wilding, G., Chen, M., & Gelmann, E. P. (1989) · The Prostate · doi:10.1002/pros.2990140204 · Cited by 205
Lee, C. (1995) · Endocrinology · doi:10.1210/en.136.2.796 · Cited by 197
STEROIDS OF ADRENAL ORIGIN METABOLIZED BY HUMAN PROSTATIC TISSUE BOTH IN VIVO AND IN VITRO
HARPER, M. E., PIKE, A., PEELING, W. B., & GRIFFITHS, K. (1974) · Journal of Endocrinology · doi:10.1677/joe.0.0600117 · Cited by 190
Microsatellite Mutation (Cag24→18) in the Androgen Receptor Gene in Human Prostate Cancer
Schoenberg, M. P., Hakimi, J. M., Wang, S. P., Bova, G. S., Epstein, J. I., Fischbeck, K. H., Isaacs, W. B., Walsh, P. C., & Barrack, E. R. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1011 · Cited by 166
Veldscholte, J., Voorhorst-Ogink, M. M., Bolt-de Vries, J., van Rooij, H. C. J., Trapman, J., & Mulder, E. (1990) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(90)90075-o · Cited by 162
Xenografts of Primary Human Prostatic Carcinoma
Pretlow, T. G., Wolman, S. R., Micale, M. A., Pelley, R. J., Kursh, E. D., Resnick, M. I., Bodner, D. R., Jacobberger, J. W., Delmoro, C. M., Giaconia, J. M., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.394 · Cited by 154
Brolin, J., Ekman, P., & Skoog, L. K. (1992) · The Prostate · doi:10.1002/pros.2990200404 · Cited by 150
Elo, J. P., Kvist, L. J., Leinonen, K. A., ISOMAA, V. V., Henttu, P. M. A., Lukkarinen, O. A., & Vihko, P. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.12.8530589 · Cited by 143
Androgen Receptor Mutations in Prostate Cancer
Gelmann, E. P. (1996) · Cancer treatment and research · doi:10.1007/978-1-4613-1267-3_12 · Cited by 135
Sartor, O. A., Cooper, M. R., Weinberger, M., Headlee, D. J., Thibault, A., Tompkins, A. C., Steinberg, S. M., Figg, W. D., Linehan, W. M., & Myers, C. E. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.3.222 · Cited by 134
Response elements of the androgen-regulated C3 gene.
Tan, J.-A., Marschke, K. B., Ho, K. C., Perry, S. T., Wilson, E. M., & French, F. S. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42855-4 · Cited by 129
Self-citationBrown, T. R., Lubahn, D. B., Wilson, E., French, F. S., Migeon, C. J., & Corden, J. L. (1990) · Molecular Endocrinology · doi:10.1210/mend-4-12-1759 · Cited by 125
Gumerlock, P. H., Tang, Y., Meyers, F. J., & Silva, J. (1991) · Clinical Infectious Diseases · doi:10.1093/clinids/13.6.1053 · Cited by 101
Olea, N., Sakabe, K., Soto, A. M., & Sonnenschein, C. (1990) · Endocrinology · doi:10.1210/endo-126-3-1457 · Cited by 92
Prevalence of androgen receptor gene mutations in latent prostatic carcinomas from Japanese men.
Takahashi, H., Furusato, M., Allsbrook, W. C., Nishii, H., Wakui, S., Barrett, J. C., & Boyd, J. A. (1995) · PubMed · Cited by 91
Kemppainen, J., & Wilson, E. M. (1996) · Urology · doi:10.1016/s0090-4295(96)00117-3 · Cited by 86
Peterziel, H., Čulig, Z., Stober, J., Hobisch, A., Radmayr, C., Bartsch, G. H., Klocker, H., & Cato, A. C. B. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910630415 · Cited by 79
Expression of Recombinant Androgen Receptor in Cultured Mammalian Cells
Quarmby, V. E., Kemppainen, J., Sar, M., Lubahn, D. B., French, F. S., & Wilson, E. M. (1990) · Molecular Endocrinology · doi:10.1210/mend-4-9-1399 · Cited by 70
Human Androgen Receptor Expression in Prostate Cancer following Androgen Ablation
White, R. D., Meyers, F. J., Chi, S.-G., Chamberlain, S., Siders, D. B., Lee, F., STEWART, S. L., & Gumerlock, P. H. (1997) · European Urology · doi:10.1159/000474409 · Cited by 70
Bellis, A. D., Quigley, C. A., Cariello, N. F., Awady, M. K. E., Sar, M., Lane, M. V., Wilson, E. M., & French, F. S. (1992) · Molecular Endocrinology · doi:10.1210/mend.6.11.1480178 · Cited by 69
Enzymes of Androgen Formation and Degradation in the Human Prostate
BARTSCH, W., Klein, H., Schiemann, U., Bauer, H. W., & Voigt, K. D. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb34282.x · Cited by 66
Interaction of antiandrogen-androgen receptor complexes with DNA and transcription activation
Warriar, N., Pagé, N., Koutsilieris, M., & Govindan, M. V. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90311-j · Cited by 21
Cited by
Androgen Receptor in Prostate Cancer
Heinlein, C. A., & Chang, C. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0032 · Cited by 1,780
Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer
Watson, P. A., Arora, V. K., & Sawyers, C. L. (2015) · Nature Reviews Cancer · doi:10.1038/nrc4016 · Cited by 1,536
Molecular Biology of the Androgen Receptor
Gelmann, E. P. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.10.018 · Cited by 942
Nelson, W. G., De Marzo, A. M., & Isaacs, W. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021562 · Cited by 918
The Androgen Axis in Recurrent Prostate Cancer
Mohler, J. L., Gregory, C. W., Ford, O. H., Kim, D., Weaver, C. M., Petrusz, P., Wilson, E. M., & French, F. S. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1146-03 · Cited by 675
Self-citation
Metadata
- Authors
- Tan, J.-A.
- Venue
- Molecular Endocrinology
- Publisher
- The Endocrine Society
- Published
- 1997-04-01
- Volume
- 11
- Issue
- 4
- Pages
- 450-459
- ISSN
- 0888-8809 (ISSN-L)
- OpenAlex
- W2153354003
- Cited by
- 375
- References
- 47
- FWCI
- 11.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.